The Cancer Treatment Center of America, otherwise known more commonly by the curt acronym, CTCA, has recently partnered with two prominent healthcare companies, AllScripts and NantHealth respectively, to further their ceaseless campaign to combat the scourge of cancer all across the United States of America. This partnership enables what is being referred to as a eviti connection which can prove tremendously helpful for those seeking cancer treatment solutions. Eviti Connect is not a drug or pharmaceutical solution but rather a clinical program which aids prospective cancer patients by speeding up, streamlining and optimizing the sometimes difficult and complication claims processing procedure by pre-adjusting the patients claim in advance of their processing. The Eviti system is also highly reliable as it was created with the assistance and research efforts of hundreds of oncologists (those who deal medically with cancers and tumors, ect.) and boasts a considerable database on all of the latest cancer research methodologies and treatments which means processing is not only optimized but also potential treatment courses.
The healthcare partnership work which established the Eviti system from the CTCA, NantHealth and AllScripts has been highly lauded by all manner of health care professionals who attest to its veracity and functional utility. One of these medical professionals includes George Daneker, a MD and the chief medical operative of the Cancer Treatment Centers of America who stated in a recent public interview that Eviti not only eliminates potential guessing in treatment courses by clinicians, it also provides them with new tools for new course of action which otherwise would not be known to them.
The Cancer Treatment Centers of America, based out of Florida, has a long history of such innovative health care work and is consistently rated as possessing the very best hospitals in the whole of the United States of America. The Eviti system is just one more way they are helping make their mark in increasingly hopeful struggle against cancer.